{"entity":"cvs-health","id":"ent_cvs-health","name":"CVS Health","from":"2025-11-09","to":"2026-11-09","page":"https://asof.is/record/cvs-health/diff?from=2025-11-09&to=2026-11-09","summary":"Between 2025-11-09 and 2026-11-09, CVS Health's record changed in 18 facts: 3 replaced (net income $4.61 billion → $1.77 billion; operating income $8.52 billion → $4.66 billion; revenue $372.81 billion → $402.07 billion), 8 added, 7 ended; 11 unchanged.","counts":{"changed":18,"added":8,"ended":7,"replaced":3,"unchanged":11,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"cash_and_equivalents","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_net_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_operating_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_revenue","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"shares_outstanding","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_assets","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_equity","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"chair","added":1,"ended":0,"replaced":0,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"operating_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"cfo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"x_username","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[{"id":"clm_C5BD452E3A6B","predicate":"cash_and_equivalents","value":"11,738,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,738,000,000 United States dollar\", as of 2026-09-30. Claim clm_C5BD452E3A6B, https://asof.is/claim/clm_C5BD452E3A6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_C5BD452E3A6B","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_CD3F5A892A25","predicate":"chair","value":"J. David Joyner","valid_from":"2026-01-01","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health chair: J. David Joyner\", as of 2026-01-01. Claim clm_CD3F5A892A25, https://asof.is/claim/clm_CD3F5A892A25, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm.","url":"https://asof.is/claim/clm_CD3F5A892A25","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm","tier":"primary","publisher":"SEC EDGAR 10-K","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"J. David Joyner , age 61, has been the President and Chief Executive Officer of CVS Health Corporation since October 2024, and Chair of the Board of Directors of CVS Health Corporation since January 2026.","url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm"}},{"id":"clm_B17E3CAA413D","predicate":"quarterly_net_income","value":"2,172,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,172,000,000 United States dollar\", as of 2026-09-30. Claim clm_B17E3CAA413D, https://asof.is/claim/clm_B17E3CAA413D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_B17E3CAA413D","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_8E2C754E23C9","predicate":"quarterly_operating_income","value":"3,566,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,566,000,000 United States dollar\", as of 2026-09-30. Claim clm_8E2C754E23C9, https://asof.is/claim/clm_8E2C754E23C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_8E2C754E23C9","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_9CC0835CD0B3","predicate":"quarterly_revenue","value":"108,399,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 108,399,000,000 United States dollar\", as of 2026-09-30. Claim clm_9CC0835CD0B3, https://asof.is/claim/clm_9CC0835CD0B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_9CC0835CD0B3","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_687FA44BD471","predicate":"shares_outstanding","value":"1,279,474,188 shares","valid_from":"2026-10-28","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,279,474,188 shares\", as of 2026-10-28. Claim clm_687FA44BD471, https://asof.is/claim/clm_687FA44BD471, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_687FA44BD471","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_B06B50BDA5DB","predicate":"total_assets","value":"258,075,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 258,075,000,000 United States dollar\", as of 2026-09-30. Claim clm_B06B50BDA5DB, https://asof.is/claim/clm_B06B50BDA5DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_B06B50BDA5DB","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_81B0FD010E0C","predicate":"total_equity","value":"80,497,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 80,497,000,000 United States dollar\", as of 2026-09-30. Claim clm_81B0FD010E0C, https://asof.is/claim/clm_81B0FD010E0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_81B0FD010E0C","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}}],"ended":[{"id":"clm_E6500192AB53","predicate":"cash_and_equivalents","value":"9,098,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,098,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_E6500192AB53, https://asof.is/claim/clm_E6500192AB53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_E6500192AB53","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A25A25B58E67","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_0A041DAEF9A0","predicate":"quarterly_net_income","value":"-3,975,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -3,975,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_0A041DAEF9A0, https://asof.is/claim/clm_0A041DAEF9A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_0A041DAEF9A0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF31176E7782","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_2A1E9B23616D","predicate":"quarterly_operating_income","value":"-3,207,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -3,207,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_2A1E9B23616D, https://asof.is/claim/clm_2A1E9B23616D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_2A1E9B23616D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9CC86217BBF1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_500FE97E42FE","predicate":"quarterly_revenue","value":"102,871,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 102,871,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_500FE97E42FE, https://asof.is/claim/clm_500FE97E42FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_500FE97E42FE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_08828AE65EA2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_0394ED778E59","predicate":"shares_outstanding","value":"1,269,432,485 shares","valid_from":"2025-10-22","valid_to":"2026-02-04","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,269,432,485 shares\", as of 2025-10-22 (until 2026-02-04). Claim clm_0394ED778E59, https://asof.is/claim/clm_0394ED778E59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_0394ED778E59","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CD167661C6C4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_C0107A345222","predicate":"total_assets","value":"255,327,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 255,327,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C0107A345222, https://asof.is/claim/clm_C0107A345222, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_C0107A345222","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D4BC175A88B3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_595EFD826535","predicate":"total_equity","value":"72,928,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 72,928,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_595EFD826535, https://asof.is/claim/clm_595EFD826535, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_595EFD826535","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_40C242560A21","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-29"}}],"replaced":[{"predicate":"net_income","from":{"id":"clm_16FF91BAD829","predicate":"net_income","value":"4,614,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,614,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_16FF91BAD829, https://asof.is/claim/clm_16FF91BAD829, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_16FF91BAD829","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_96EA4714F001","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_96EA4714F001","predicate":"net_income","value":"1,768,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 1,768,000,000 United States dollar\", as of 2025-12-31. Claim clm_96EA4714F001, https://asof.is/claim/clm_96EA4714F001, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_96EA4714F001","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-10"}}},{"predicate":"operating_income","from":{"id":"clm_1A2E653D169B","predicate":"operating_income","value":"8,516,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,516,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_1A2E653D169B, https://asof.is/claim/clm_1A2E653D169B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_1A2E653D169B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A89384995235","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_A89384995235","predicate":"operating_income","value":"4,660,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,660,000,000 United States dollar\", as of 2025-12-31. Claim clm_A89384995235, https://asof.is/claim/clm_A89384995235, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_A89384995235","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-10"}}},{"predicate":"revenue","from":{"id":"clm_444C7C41D426","predicate":"revenue","value":"372,809,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 372,809,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_444C7C41D426, https://asof.is/claim/clm_444C7C41D426, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_444C7C41D426","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B99511607945","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_B99511607945","predicate":"revenue","value":"402,067,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 402,067,000,000 United States dollar\", as of 2025-12-31. Claim clm_B99511607945, https://asof.is/claim/clm_B99511607945, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_B99511607945","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-10"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date"}}}